Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Clinical Trials
Sort By
Newest First
1 / 40
1 / 40
Approval
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences
PR-02-25-NI-16
Feb 19, 2025
Clinical Trials
EXUMA Biotech Announces Phase 1 Results for its Autologous HER2 Directed CAR-T Product at ASCO GI 2025
EXUMA Biotechnology
PR-01-25-NI-26
Feb 11, 2025
Clinical Trials
CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
Carsgen Therapeutics
PR-02-25-NI-09
Feb 11, 2025
Clinical Trials
Caliway Announces CBL-514 Second Phase 2b Study Results (CBL-0205) Met Endpoints
Caliway Biopharmaceuticals
PR-02-25-NI-08
Feb 10, 2025
Announcement
TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial
TransCode Therapeutics
PR-02-25-NI-03
Feb 07, 2025
USAID Trials
The Collapse of USAID-Funded Clinical Trials: A Blow to Global Health and Biopharma Innovation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-CL-06
Feb 06, 2025
Announcement
Avirmax Biopharma Completes First Cohort Enrollment in ABI-110 Gene Therapy Trial for Wet AMD, Including PCV.
Avirmax Biopharma
PR-01-25-NI-31
Feb 04, 2025
Financing
Vetigenics Secures $6 Million Seed Financing, Sees Meaningful Clinical Progress
Vetigenics
PR-01-25-NI-27
Feb 03, 2025
Clinical Trials
Gene Therapeutics (NGGT) Announces Publication of Early Clinical Trial Results for the Treatment of Bietti's Crystalline Dystrophy
NGGT Inc.
PR-01-25-NI-16
Jan 16, 2025
Clinical Trials
Chime Biologics and Mabgeek Achieve MG-K10 PPQ Milestone, Advancing Therapies Clinical Trials and Commercialization
Chime Biologics
PR-01-25-NI-01
Jan 03, 2025
CDMO
Navigating the Complexities of Microbial and Mammalian Manufacturing
Peter Boman; Helena Pettersson
NorthX Biologics
PAO-12-24-CL-3
Jan 02, 2025
Clinical Trials
GenBio AI Releases Phase 1 of World's First Digital Organism to Transform Medical Research
GenBio AI
PR-12-24-NI-144
Dec 19, 2024
Clinical Trials
Beacon Therapeutics Announces Positive 3-Month Data from Phase 2 DAWN Trial in Patients
Beacon Therapeutics
PR-12-24-NI-131
Dec 06, 2024
CDMO
Advancing the Science of Technical and Therapeutic Proteins
Eva-Karin Gidlund, Ph.D.
NorthX Biologics
PAO-11-24-CL-10
Dec 04, 2024
Antibody
Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-life Extended Anti-TL1A Antibodies
Spyre Therapeutics, Inc.
PR-12-24-NI-125
Dec 03, 2024
Financing
EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics
EQT
PR-11-24-NI-116
Nov 20, 2024
CRO
Lindus Health Rolls Out "All-in-One Infectious Disease CRO" Bespoke to Clinical Trials for Infectious Disease Interventions
Lindus Health
PR-11-24-NI-113
Nov 19, 2024
Clinical Trials
Concerto Biosciences Announces First Participant Dosed with Live Biotherapeutic ENS-002 in Phase 1 Trial for Atopic Dermatitis
Concerto Biosciences
PR-11-24-NI-112
Nov 19, 2024
Commissioning
Navigating the Australian Clinical Trials Landscape
CAI Commissioning Agents Inc.
PAO-11-24-RTM-05
Nov 15, 2024
Cystic Fibrosis
Spirovant Sciences Doses First Patient in Phase 1/2 Trial of Its Aerosol-Delivered Genetic Medicine for Treating Cystic Fibrosis
Spirovant Sciences
PR-11-24-NI-101
Nov 15, 2024
